1. Home
  2. JAGX vs IMNN Comparison

JAGX vs IMNN Comparison

Compare JAGX & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • IMNN
  • Stock Information
  • Founded
  • JAGX 2013
  • IMNN 1982
  • Country
  • JAGX United States
  • IMNN United States
  • Employees
  • JAGX N/A
  • IMNN N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAGX Health Care
  • IMNN Health Care
  • Exchange
  • JAGX Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • JAGX 12.9M
  • IMNN 13.8M
  • IPO Year
  • JAGX N/A
  • IMNN 1985
  • Fundamental
  • Price
  • JAGX $0.85
  • IMNN $0.91
  • Analyst Decision
  • JAGX
  • IMNN Strong Buy
  • Analyst Count
  • JAGX 0
  • IMNN 2
  • Target Price
  • JAGX N/A
  • IMNN $20.50
  • AVG Volume (30 Days)
  • JAGX 542.5K
  • IMNN 425.6K
  • Earning Date
  • JAGX 11-13-2024
  • IMNN 11-07-2024
  • Dividend Yield
  • JAGX N/A
  • IMNN N/A
  • EPS Growth
  • JAGX N/A
  • IMNN N/A
  • EPS
  • JAGX N/A
  • IMNN N/A
  • Revenue
  • JAGX $10,480,000.00
  • IMNN N/A
  • Revenue This Year
  • JAGX $18.18
  • IMNN N/A
  • Revenue Next Year
  • JAGX $40.06
  • IMNN N/A
  • P/E Ratio
  • JAGX N/A
  • IMNN N/A
  • Revenue Growth
  • JAGX N/A
  • IMNN N/A
  • 52 Week Low
  • JAGX $0.84
  • IMNN $0.48
  • 52 Week High
  • JAGX $21.60
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 39.11
  • IMNN 52.89
  • Support Level
  • JAGX $0.84
  • IMNN $0.84
  • Resistance Level
  • JAGX $1.33
  • IMNN $1.08
  • Average True Range (ATR)
  • JAGX 0.10
  • IMNN 0.08
  • MACD
  • JAGX -0.03
  • IMNN -0.00
  • Stochastic Oscillator
  • JAGX 1.04
  • IMNN 46.16

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About IMNN Imunon Inc.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Share on Social Networks: